Alzheimer's drug tracer study maps brain uptake in healthy volunteers
NCT ID NCT06454721
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study looked at how a drug being tested for Alzheimer's disease, called BIIB080, spreads through the brain and spinal cord. Five healthy adults received a tiny radioactive version of the drug along with a regular dose, then had PET scans to track it. The main goal was to measure where the drug goes in the central nervous system and to check for any safety issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.